Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia

References

• Office of Applied Studies—Substance Abuse and Mental Health Services Administration. Emergency department trends from DAWN: final estimates 1995 – 2002. USA Department of Health and Human Services, Rockville, MD 2003, DAWN Series D-24, DHHS publication no. (SMA) 03-3780
   Google Scholar
• Johnston L D, O'Malley P M, Bachman J G. National survey results on drug use from the Monitoring the Future study, 1975 – 2003. National Institute on Drug Abuse, Rockville, MD 2003
   Google Scholar
• McCabe S E, Teter C, Boyd C J. Illicit use of prescription pain medication among college students. Drug Alcohol Depend 2005; 77: 37–47
   PubMed Web of Science ®Google Scholar
• Fry C, Bruno R. Recent trends in benzodiazepine use by injecting drug users in Victoria and Tasmania. Drug Alcohol Rev 2002; 21: 363–367
   PubMed Web of Science ®Google Scholar
• Breen C, Degenhardt L, Bruno R, Roxburgh A, Jenkinson R. The impact of the restriction of publicly subsidised 10 mg temazepam capsules upon benzodiazepine use among injecting drug users in Australia. Med J Aust 2004; 181: 300–305
   PubMed Web of Science ®Google Scholar
• Iguchi M Y, Handelsman L, Bickel W K, Griffiths R R. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 1993; 32: 257–266
   PubMed Web of Science ®Google Scholar
• Dupont R L. Abuse of benzodiazepines: the problems and the solutions. Am J Drug Alcohol Abuse 1998; 14(suppl. 1)1–69
   Google Scholar
• Strang J, Griffiths P, Abbey J, Gossop M. Survey of injected benzodiazepines among drug users in Britain. BMJ 1994; 308: 1082
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Hall W. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug Alcohol Depend 1996; 43: 191–198
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Lenne M, Ritter A. Methadone injecting in Australia: a tale of two cities. Addiction 1999; 94: 1175–1178
   PubMed Web of Science ®Google Scholar
• Tacke U. Abuse of buprenorphine by intravenous injection—the French connection[comment]. Addiction 2002; 97: 1355
   PubMedGoogle Scholar
• Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti J P. Injecting misuse of buprenorphine among French drug users. Addiction 2001; 96: 267–272
   PubMed Web of Science ®Google Scholar
• Valenciano M, Emmanuelli J, Lert F. Unsafe injecting practices among attendees of syringe exchange programmes in France [see comment]. Addiction 2001; 96: 597–606
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Zador D, Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992 – 1996. Drug Alcohol Depend 2000; 60: 141–150
   PubMed Web of Science ®Google Scholar
• Auriacombe M, Franques P, Tignol J. Deaths attributable to methadone vs. buprenorphine in France. JAMA 2001; 285: 3
   Google Scholar
• Oliver P, Keen J, Rowse G, Mathers N. Deaths from drugs of abuse in Sheffield, 1998: the role of prescribed medication. Br J Gen Pract 2001; 51: 394–396
   PubMed Web of Science ®Google Scholar
• Bedford K R, Nolan S L, Onrust R, Siegers J D. The illicit preparation of morphine and heroin from pharmaceutical products containing codeine: ‘homebake’ laboratories in New Zealand. Forensic Sci Int 1987; 34: 197–204
   PubMedGoogle Scholar
• Zacny J, Bigelow G, Compton P, Foley K, Iguchi M Y, Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 2003; 69: 215–232
   PubMed Web of Science ®Google Scholar
• Hando J, O'Brien S, Darke S, Maher L, Hall W. The Illicit Drug Reporting System trial: final report. National Drug and Alcohol Research Centre, University of New South Wales, Sydney 1997, Monograph no. 31
   Google Scholar
• Bruno R, Mclean S. Tasmanian Drug Trends 2003: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2004, NDARC Technical Report no. 178
   Google Scholar
• Moon C. Northern Territory Drug Trends 2003: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2004, NDARC Technical Report no. 181
   Google Scholar
• Breen C, Degenhardt L, Roxburgh A, et al. Australian drug trends 2003: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of NSW, Sydney 2004, NDARC Monograph no. 50
   Google Scholar
• Roxburgh A, Breen C, Degenhardt L. New South Wales drug trends 2003: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2004, NDARC Technical Report no. 174
   Google Scholar
• Jenkinson R, Miller P, Fry C. Victorian Drug Trends 2003: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2004, NDARC Technical Report no. 175
   Google Scholar
• Jenkinson R, Clark N, Fry C, Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?. Addiction 2005; 100: 197–205
   PubMed Web of Science ®Google Scholar
• Darke S, Topp L, Ross J. The injection of methadone and benzodiazepines among Sydney IDU 1996 – 2000: 5-year monitoring of trends from the Illicit Drug Reporting System (IDRS). Drug Alcohol Rev 2002; 21: 27–32
   PubMed Web of Science ®Google Scholar
• Breen C, Degenhardt L, Roxburgh A, et al. Australian drug trends 2002: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of NSW, Sydney 2003, NDARC Monograph no. 50
   Google Scholar
• McKetin R, Darke S, Humeniuk R, et al. Australian drug trends 1999: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2000, NDARC Monograph no. 43
   Google Scholar
• Stafford J, Degenhardt L, Black E, et al. Australian drug trends 2004: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2005, NDARC Monograph no. 55
   Google Scholar
• Topp L, Barker B, Degenhardt L. The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug Alcohol Depend 2004; 73: 33–40
   PubMed Web of Science ®Google Scholar
• Topp L, Darke S, Bruno R, et al. Australian drug trends 2000: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2001, NDARC Monograph no. 47
   Google Scholar
• Topp L, Kaye S, Bruno R, et al. Australian Drug Trends 2001. Findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2002, NDARC Monograph no. 48
   Google Scholar
• Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcomes of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992; 87: 733–742
   PubMedGoogle Scholar
• Darke S, Cohen J, Ross J, Hando J, Hall W. Transitions between routes of administration of regular amphetamine users. Addiction 1994; 89: 1683–1690
   PubMed Web of Science ®Google Scholar
• O'Reilly B, Rysavy P. Northern Territory drug trends 2000: findings of the Illicit Drug Reporting System. National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2001
   Google Scholar
• Australian Bureau of Statistics. 3222.0 population projections, Australia 2002 – 2101. Australian Government Printing Service, Canberra 2003
   Google Scholar
• Bruno R. Tasmanian drug trends 2004: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2005, NDARC Technical Report no. 215
   Google Scholar
• Day C, Degenhardt L, Hall W. Documenting the heroin shortage in New South Wales. Drug Alcohol Rev 2006; 25: 297–305
   PubMed Web of Science ®Google Scholar
• O'Reilly B, Leibrick F, Chenhall R. An exploration of the crime and policing implications of an illicit opiate market dominated by prescription morphine. 15th International Conference on the Reduction of Drug Related Harm, MelbourneAustralia, 2004
   Google Scholar
• O'Reilly B. Northern Territory drug trends 2001: findings of the Illicit Drug Reporting System. National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2002, NDARC Technical Report no. 137
   Google Scholar
• World Health Organization. Achieving balance in national opioids control policy. Guidelines for assessment. World Health Organization, GenevaSwitzerland 2000
   Google Scholar